Bezafibrate Exerts Neuroprotective Effects in a Rat Model of Sporadic Alzheimer’s Disease

Bezafibrate, a pan-peroxisome proliferator-activated receptor (PPAR) agonist, reportedly attenuated tau pathology in a transgenic mouse model of primary tauopathy. Since tau pathology is a neuropathological hallmark of Alzheimer’s disease (AD), bezafibrate may be a potential drug for the treatment o...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Li-Fan, Jhao, Yun-Ting, Chiu, Chuang-Hsin, Sun, Lu-Han, Chou, Ta-Kai, Shiue, Chyng-Yann, Cheng, Cheng-Yi, Ma, Kuo-Hsing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877080/
https://www.ncbi.nlm.nih.gov/pubmed/35215222
http://dx.doi.org/10.3390/ph15020109

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8877080/
https://www.ncbi.nlm.nih.gov/pubmed/35215222
http://dx.doi.org/10.3390/ph15020109

Ejemplares similares